TOP2A and non-small cell lung carcinoma: This study aims to provide a clinical basis for the early and specific diagnosis of NSCLC and an improvement in its prognosis by analyzing the potential relationship between TOP2A and ADH1B genes and lipid metabolism as well as prognosis in NSCLC patients.